3-Oxopyridazin-5-yl-Chalcone Hybrids : Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation
作者： Abdelaziz El Maatougui , Matilde Yáñez , Abel Crespo , Nuria Fraiz , Alberto Coelho
关键词: Glycoprotein IIb/IIIa 、 Chalcone 、 Platelet aggregation inhibitor 、 Stereochemistry 、 Chemistry 、 Platelet
摘要: A novel family of potent and broad-spectrum antiplatelet agents has been discovered by exploration a library 3-oxopyridazin-5-yl-chalcone hybrids. The pharmacological evaluation the collec ...
sci-hub.se 参考文章(41)
I. Ahrens, C. Bode, K. Peter, Inhibition of platelet activation and aggregation. Handbook of experimental pharmacology. ,vol. 170, pp. 443- 462 ,(2005) , 10.1007/3-540-27661-0_16
Khaled R. A. Abdellatif, Eman K. A. Abdelall, Wael A. A. Fadaly, Gehan M. Kamel, Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring Medicinal Chemistry Research. ,vol. 24, pp. 2632- 2644 ,(2015) , 10.1007/S00044-015-1327-7
J S Bennett, S J Shattil, J W Power, T K Gartner, Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. Journal of Biological Chemistry. ,vol. 263, pp. 12948- 12953 ,(1988) , 10.1016/S0021-9258(18)37654-3
Joanne M. Smallheer, Richard E. Olson, Ruth R. Wexler, Chapter 10. Antiplatelet therapies Annual Reports in Medicinal Chemistry. ,vol. 35, pp. 103- 122 ,(2000) , 10.1016/S0065-7743(00)35011-4
Aaron J. Marcus, Lenore B. Safier, Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis The FASEB Journal. ,vol. 7, pp. 516- 522 ,(1993) , 10.1096/FASEBJ.7.6.8472890
Omair Yousuf, Deepak L. Bhatt, The evolution of antiplatelet therapy in cardiovascular disease Nature Reviews Cardiology. ,vol. 8, pp. 547- 559 ,(2011) , 10.1038/NRCARDIO.2011.96
Alberto Coelho, Enrique Raviña, Nuria Fraiz, Matilde Yáñez, Reyes Laguna, Ernesto Cano, Eddy Sotelo, Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity. Journal of Medicinal Chemistry. ,vol. 50, pp. 6476- 6484 ,(2007) , 10.1021/JM061401D
Jean-Michel Dogne, Xavier Leval, Patricia Benoit, Jacques Delarge, Bernard Masereel, Jean-Louis David, Recent advances in antiplatelet agents. Current Medicinal Chemistry. ,vol. 9, pp. 577- 589 ,(2002) , 10.2174/0929867024606948
Jacques R. Leclerc, Platelet glycoprotein IIb/IIIa antagonists: Lessons learned from clinical trials and future directions Critical Care Medicine. ,vol. 30, ,(2002) , 10.1097/00003246-200205001-00025
Shaker A Mousa, None, Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond. Current Pharmaceutical Design. ,vol. 9, pp. 2317- 2322 ,(2003) , 10.2174/1381612033453893